Literature DB >> 1737765

Iron-catalyzed oxidative modification of glucose-6-phosphate dehydrogenase from Leuconostoc mesenteroides. Structural and functional changes.

L I Szweda1, E R Stadtman.   

Abstract

As a variety of eukaryotic cells age, the specific activity of glucose-6-phosphate dehydrogenase (Glu-6-PDH) declines as much as 50%. Because of the central role of this enzyme in metabolism, it is important to define factors responsible for this loss in enzyme activity. We report that Glu-6-PDH from Leuconostoc mesenteroides is rapidly inactivated by micromolar concentrations of Fe2+ and H2O2. Inactivation correlated with the formation of one carbonyl functionality/enzyme subunit, indicating that inactivation is the result of site-specific oxidative modification. Our results suggest that Fe2+ binds to the glucose 6-phosphate binding site and that interaction of the enzyme-bound Fe2+ with H2O2 leads to the oxidative modification of amino acids essential for enzyme activity. Partially inactivated enzyme remained predominantly in the dimeric form, and no change in the apparent affinity of the remaining active subunits for substrate was observed. Partial inactivation did, however, lead to a decrease in the thermal stability of the remaining activity. This decrease in thermal stability could be largely overcome by the addition of glucose 6-phosphate. Thus, although exposure to H2O2 and Fe2+ results in the irreversible inactivation of Glu-6-PDH, the resulting modification is selective, leads to the formation of heterodimers of both active and inactive subunits, and does not appear to cause large scale structural changes. Our results demonstrate the inherent susceptibility of Glu-6-PDH from L. mesenteroides to modification by an oxidation system known to exist in vivo. An assessment of the physiological significance of Fe(2+)-catalyzed oxidation of Glu-6-PDH awaits extension of these studies to mammalian sources known to accumulate less active or inactive forms of the enzyme as a function of age.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1737765

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Activation of the ATP.Mg-dependent type 1 protein phosphatase by the Fe2+/ascorbate system.

Authors:  J S Yu; W H Chan; S D Yang
Journal:  J Protein Chem       Date:  1996-07

2.  Inactivation of the plasma membrane ATPase of Schizosaccharomyces pombe by hydrogen peroxide and by the Fenton reagent (Fe2+/H2O2): nonradical vs. radical-induced oxidation.

Authors:  K Sigler; G Gille; V Vacata; N Stadler; M Höfer
Journal:  Folia Microbiol (Praha)       Date:  1998       Impact factor: 2.099

3.  Oxidative modification and aggregation of creatine kinase from aged mouse skeletal muscle.

Authors:  Jonathan E Nuss; James K Amaning; C Eric Bailey; James H DeFord; Vincent L Dimayuga; Jeffrey P Rabek; John Papaconstantinou
Journal:  Aging (Albany NY)       Date:  2009-05-22       Impact factor: 5.682

Review 4.  Zinc and the modulation of redox homeostasis.

Authors:  Patricia I Oteiza
Journal:  Free Radic Biol Med       Date:  2012-08-25       Impact factor: 7.376

5.  AMP-deaminase from goldfish white muscle: regulatory properties and redistribution under exposure to high environmental oxygen level.

Authors:  Volodymyr I Lushchak; Viktor V Husak; Janet M Storey; Kenneth B Storey
Journal:  Fish Physiol Biochem       Date:  2008-10-18       Impact factor: 2.794

Review 6.  The effect of muscle-damaging exercise on blood and skeletal muscle oxidative stress: magnitude and time-course considerations.

Authors:  Michalis G Nikolaidis; Athanasios Z Jamurtas; Vassilis Paschalis; Ioannis G Fatouros; Yiannis Koutedakis; Dimitris Kouretas
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

Review 7.  Redox regulation of antioxidants, autophagy, and the response to stress: implications for electrophile therapeutics.

Authors:  Anna-Liisa Levonen; Bradford G Hill; Emilia Kansanen; Jianhua Zhang; Victor M Darley-Usmar
Journal:  Free Radic Biol Med       Date:  2014-03-26       Impact factor: 7.376

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.